BioHermes A1C EZ 2.0 Glycohemoglobin Analyzer

The HbA1c, a byproduct of non-enzymatic glycation resulting from the interaction between hemoglobin and plasma glucose, serves as a remarkable indicator of average glycemic levels over an extended period. It stands as a fundamental tool to assess the effectiveness of Diabetes Management and holds significant prognostic value for complications associated with the condition. Lowering HbA1c levels has shown a tangible reduction in such complications.

An HbA1c level equal to or surpassing 6.5% (48 mmol/mol) is one of the benchmarks employed in diagnosing diabetes. The normal range for HbA1c falls between 4.0% and 5.7% (20-39 mmol/mol), while values ranging from 5.7% to 6.4% (39-46 mmol/mol) indicate prediabetes.
The point-of-care HbA1c Test facilitates swift adjustments in treatment, offering a timely opportunity for intervention. The Bioherms A1C EZ 2.0 Glycohemoglobin Analyzer employs Boronate Affinity Chromatography, ensuring exceptional precision with an accuracy of ≤3%. By utilizing a mere droplet of blood obtained from either a fingertip or a vein, results can be obtained within a mere 5 minutes.

Considering the convenience of transportation and storage, the Glycohemoglobin Test Kit is designed to be stored at room temperature. This decision also aligns with BioHermes’ commitment to addressing the environmental impact of cold room storage and its contribution to global warming.